149 related articles for article (PubMed ID: 27609582)
1. [Increased expressions of programmed death 1 (PD-1) and its ligands in peripheral CD3(+) T cells and CD19(+) B cells in patients with hepatocellular carcinoma].
Liu W; Chai L; Liang J; Lu Z; Yang S
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Sep; 32(9):1243-7. PubMed ID: 27609582
[TBL] [Abstract][Full Text] [Related]
2. Long-term use of indomethacin leads to poor prognoses through promoting the expression of PD-1 and PD-L2 via TRIF/NF-κB pathway and JAK/STAT3 pathway to inhibit TNF-α and IFN-γ in hepatocellular carcinoma.
Xu P; Sun Z; Wang Y; Miao C
Exp Cell Res; 2015 Sep; 337(1):53-60. PubMed ID: 26162855
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of bovine programmed death-ligand 2.
Nishimori A; Konnai S; Ikebuchi R; Okagawa T; Nakajima C; Suzuki Y; Mingala CN; Murata S; Ohashi K
Microbiol Immunol; 2014 Jul; 58(7):388-97. PubMed ID: 24845976
[TBL] [Abstract][Full Text] [Related]
4. Accumulation of CD5
Wlasiuk P; Niedzielski A; Skorka K; Karczmarczyk A; Zaleska J; Zajac M; Putowski M; Pac-Kozuchowska E; Giannopoulos K
Clin Exp Med; 2016 Nov; 16(4):503-509. PubMed ID: 26319791
[TBL] [Abstract][Full Text] [Related]
5. PD-1/PD-L1 pathway activation restores the imbalance of Th1/Th2 and treg/Th17 cells subtypes in immune thrombocytopenic purpura patients.
Wu D; Liu Y; Pang N; Sun M; Wang X; Haridia Y; Zhao F; Qin Y; Fan W; Guo X; Ding J
Medicine (Baltimore); 2019 Oct; 98(43):e17608. PubMed ID: 31651870
[TBL] [Abstract][Full Text] [Related]
6. Increased PD-1 on CD4(+)CD28(-) T cell and soluble PD-1 ligand-1 in patients with T2DM: association with atherosclerotic macrovascular diseases.
Shi B; Du X; Wang Q; Chen Y; Zhang X
Metabolism; 2013 Jun; 62(6):778-85. PubMed ID: 23398844
[TBL] [Abstract][Full Text] [Related]
7. [Upregulated PD-1 on CD8
Xiao J; Liu X; Yu X; Dong Y; Wang X; Leng J; Yang R; Wang Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Oct; 32(10):1372-1377. PubMed ID: 27667465
[TBL] [Abstract][Full Text] [Related]
8. Programmed death-1
Singh A; Mohan A; Dey AB; Mitra DK
Clin Exp Immunol; 2017 Feb; 187(2):269-283. PubMed ID: 27665733
[TBL] [Abstract][Full Text] [Related]
9. IFN-γ decreased the suppressive function of CD33
Zhan X; Hu S; Wu Y; Li M; Liu T; Ming S; Wu M; Liu M; Huang X
Mol Immunol; 2018 Feb; 94():107-120. PubMed ID: 29291452
[TBL] [Abstract][Full Text] [Related]
10. High programmed death 1 expression on T cells in aplastic anemia.
Zhao W; Zhang Y; Zhang P; Yang J; Zhang L; He A; Zhang W; Hideto T
Immunol Lett; 2017 Mar; 183():44-51. PubMed ID: 28153603
[TBL] [Abstract][Full Text] [Related]
11. Immunostaining of PD-1/PD-Ls in liver tissues of patients with hepatitis and hepatocellular carcinoma.
Wang BJ; Bao JJ; Wang JZ; Wang Y; Jiang M; Xing MY; Zhang WG; Qi JY; Roggendorf M; Lu MJ; Yang DL
World J Gastroenterol; 2011 Jul; 17(28):3322-9. PubMed ID: 21876620
[TBL] [Abstract][Full Text] [Related]
12. PD-1 and PD-L1 upregulation promotes CD8(+) T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients.
Shi F; Shi M; Zeng Z; Qi RZ; Liu ZW; Zhang JY; Yang YP; Tien P; Wang FS
Int J Cancer; 2011 Feb; 128(4):887-96. PubMed ID: 20473887
[TBL] [Abstract][Full Text] [Related]
13. Variable increased expression of program death-1 and program death-1 ligands on peripheral mononuclear cells is not impaired in patients with systemic lupus erythematosus.
Liu MF; Weng CT; Weng MY
J Biomed Biotechnol; 2009; 2009():406136. PubMed ID: 19759858
[TBL] [Abstract][Full Text] [Related]
14. PD-1, PD-L1 and PD-L2 Gene Expression on T-Cells and Natural Killer Cells Declines in Conjunction with a Reduction in PD-1 Protein during the Intensive Phase of Tuberculosis Treatment.
Hassan SS; Akram M; King EC; Dockrell HM; Cliff JM
PLoS One; 2015; 10(9):e0137646. PubMed ID: 26359860
[TBL] [Abstract][Full Text] [Related]
15. Programmed death-ligand 1, 2 expressions are decreased in the psoriatic epidermis.
Kim DS; Je JH; Kim SH; Shin D; Kim TG; Kim DY; Kim SM; Lee MG
Arch Dermatol Res; 2015 Aug; 307(6):531-8. PubMed ID: 26133691
[TBL] [Abstract][Full Text] [Related]
16. [Expression of PD-1/PD-L1 in peripheral blood mononuclear cells in lung cancer patients and its biological significance].
Xu P; Chen H; Chen YJ; Chen YB; Gu GH; Wu MY; Wu MJ; Wang XF; Zhang XG
Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):910-3. PubMed ID: 24506960
[TBL] [Abstract][Full Text] [Related]
17. [PD-L1/PD-L2 on human placenta-derived mesenchymal stem cells inhibits the IL-17 secretion of peripheral blood T cells].
Wang G; Wang F; Li H; Zhang L; Luan X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Feb; 29(2):132-6. PubMed ID: 23388330
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of programmed death ligands in naturally occurring postweaning multisystemic wasting syndrome.
Yue F; Cheng A; Zhu Y; Li P; Zhang Y; Sun G; Wang M; Wang X
Viral Immunol; 2015 Mar; 28(2):101-6. PubMed ID: 25594677
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of Immunosuppressive Molecules, PD-1 and PD-L1 but not PD-L2, in the Patients with Multiple Sclerosis.
Javan MR; Aslani S; Zamani MR; Rostamnejad J; Asadi M; Farhoodi M; Nicknam MH
Iran J Allergy Asthma Immunol; 2016 Aug; 15(4):296-302. PubMed ID: 27921410
[TBL] [Abstract][Full Text] [Related]
20. The expression of programed death ligand-1 could be related with unfavorable prognosis in salivary duct carcinoma.
Sato F; Akiba J; Kawahara A; Naito Y; Ono T; Takase Y; Murata K; Abe H; Yamaguchi T; Miyoshi H; Abe Y; Mihara Y; Tanikawa M; Akashi M; Kurose H; Umeno H; Yano H
J Oral Pathol Med; 2018 Aug; 47(7):683-690. PubMed ID: 29719073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
